Skip to search formSkip to main contentSkip to account menu

pivagabine

Known as: N-trimethylacetyl-4-aminobutyric acid, pivagabin, N-trimethylacetyl GABA 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Tonerg
analogs & derivatives

Broader (1)

gamma-Aminobutyric Acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Pivagabine effects on neuroendocrine responses to experimentally-induced psychological stress in humans
2000
2000
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea
Stress-induced neuroendocrine activities influence the regulation of endocrine glands and axes. Weight loss-related hypothalamic… 
1999
1999
Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain
1997
1997
Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress.
The effect of pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4, Tonerg), a synthetic molecule with… 
Review
1997
Review
1997
Pivagabine: a novel psychoactive drug.
Pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4, Tonerg) is a metabolically stable compound with a… 
1997
1997
Role of pivagabine in the treatment of climacteric syndrome.
A multicenter, double-blind, controlled study of pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4… 
1997
1997
Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.
The efficacy of a new drug, pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4, Tonerg), was studied on… 
1997
1997
Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
One hundred and eighteen patients with neurasthenia, as defined by ICD 10 (International Classification of Diseases… 
1997
1997
Use of pivagabine in the management of hospitalization distress in children.
A double-blind, placebo-controlled study was performed in order to evaluate the efficacy of pivagabine (4-[(2,2-dimethyl-1… 
1997
1997
Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.
Depression and distress have in common hypercortisolism, a high turn-over of cerebral monoamines and a wide clinical variability… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)